Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring.

Klein A, Otto G, Krämer I.

Transplantation. 2009 Mar 27;87(6):839-47. doi: 10.1097/TP.0b013e318199d122.

PMID:
19300186
[PubMed - indexed for MEDLINE]
2.

Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications.

Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT.

Clin Transplant. 2001 Oct;15(5):330-6.

PMID:
11678959
[PubMed - indexed for MEDLINE]
3.

Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimen.

Eberlin M, Otto G, Krämer I.

Transplant Proc. 2013 Jul-Aug;45(6):2314-20. doi: 10.1016/j.transproceed.2012.10.037. Epub 2013 May 29.

PMID:
23726723
[PubMed - indexed for MEDLINE]
4.

Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.

Fisher RA, Stone JJ, Wolfe LG, Rodgers CM, Anderson ML, Sterling RK, Shiffman ML, Luketic VA, Contos MJ, Mills AS, Ferreira-Gonzalez A, Posner MP.

Clin Transplant. 2004 Aug;18(4):463-72.

PMID:
15233827
[PubMed - indexed for MEDLINE]
5.

Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.

Langrehr JM, Klupp J, Glanemann M, Junge G, Pfitzmann R, Bahra M, Radtke C, Neumann U, Neuhaus R, Neuhaus P.

Clin Transplant. 2006 May-Jun;20(3):272-83.

PMID:
16824141
[PubMed - indexed for MEDLINE]
6.

Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.

Eckhoff DE, McGuire BM, Frenette LR, Contreras JL, Hudson SL, Bynon JS.

Transplantation. 1998 Jan 27;65(2):180-7.

PMID:
9458011
[PubMed - indexed for MEDLINE]
7.

Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.

Mardigyan V, Tchervenkov J, Metrakos P, Barkun J, Deschenes M, Cantarovich M.

Clin Ther. 2005 Apr;27(4):463-9.

PMID:
15922819
[PubMed - indexed for MEDLINE]
8.

Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.

Stegall MD, Wachs ME, Everson G, Steinberg T, Bilir B, Shrestha R, Karrer F, Kam I.

Transplantation. 1997 Dec 27;64(12):1755-60.

PMID:
9422416
[PubMed - indexed for MEDLINE]
9.

Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.

Jain A, Mazariegos G, Kashyap R, Green M, Gronsky C, Starzl TE, Fung J, Reyes J.

Transplantation. 2000 Aug 27;70(4):617-25.

PMID:
10972220
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

New strategies using 'low-dose' mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation.

Ulsh PJ, Yang HC, Holman MJ, Ahsan N.

J Transpl Coord. 1999 Jun;9(2):114-8.

PMID:
10703393
[PubMed - indexed for MEDLINE]
12.

Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.

Ahsan N, Hricik D, Matas A, Rose S, Tomlanovich S, Wilkinson A, Ewell M, McIntosh M, Stablein D, Hodge E.

Transplantation. 1999 Dec 27;68(12):1865-74.

PMID:
10628766
[PubMed - indexed for MEDLINE]
13.

A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.

Jain A, Kashyap R, Demetris AJ, Eghstesad B, Pokharna R, Fung JJ.

Liver Transpl. 2002 Jan;8(1):40-6.

PMID:
11799484
[PubMed - indexed for MEDLINE]
Free Article
14.

Comparing renal transplant patients' adherence to free cyclosporine and free tacrolimus immunosuppressant therapy.

Chisholm MA, Mulloy LL, DiPiro JT.

Clin Transplant. 2005 Feb;19(1):77-82.

PMID:
15659138
[PubMed - indexed for MEDLINE]
15.

Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results.

Reich DJ, Clavien PA, Hodge EE; MMF Renal Dysfunction after Liver Transplantation Working Group.

Transplantation. 2005 Jul 15;80(1):18-25.

PMID:
16003228
[PubMed - indexed for MEDLINE]
16.

A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year.

Ciancio G, Burke GW, Gaynor JJ, Mattiazzi A, Roth D, Kupin W, Nicolas M, Ruiz P, Rosen A, Miller J.

Transplantation. 2004 Jan 27;77(2):252-8.

PMID:
14742990
[PubMed - indexed for MEDLINE]
17.

Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.

Gruessner RW.

Clin Transplant. 1997 Aug;11(4):299-312.

PMID:
9267719
[PubMed - indexed for MEDLINE]
18.

Impact of cyclosporine on the development of immunosuppressive therapy in liver transplantation.

Casanovas Taltavull T.

Transplant Proc. 2004 Mar;36(2 Suppl):291S-294S. Review.

PMID:
15041355
[PubMed - indexed for MEDLINE]
19.

Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2005 May;9(21):1-179, iii-iv. Review.

PMID:
15899149
[PubMed - indexed for MEDLINE]
Free Article
20.

Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.

Musuamba FT, Rousseau A, Bosmans JL, Senessael JJ, Cumps J, Marquet P, Wallemacq P, Verbeeck RK.

Clin Pharmacokinet. 2009;48(11):745-58. doi: 10.2165/11318060-000000000-00000.

PMID:
19817503
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk